Home Compliance Life Sciences Companies Face Continuing Compliance Challenges in Developing Value-Based and Value-Added... ComplianceExpert Opinion Life Sciences Companies Face Continuing Compliance Challenges in Developing Value-Based and Value-Added Models January 5, 2024 7 Share FacebookLinkedinTwitter H_Ko | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Relator Alleged Violation of Statutes But Didn’t Adequately Plead False Certification Compliance OFCCP Releases New Artificial Intelligence Guidance Compliance Keeping the Lodestar Local — Mississippi Court Refuses to Apply D.C. Rates for FCA Fee Award